Automated Fundus Image Quality Assessment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Manual review of retinal images for diabetic retinopathy diagnosis is labor-intensive and prone to errors, requiring efficient automation for accurate and timely disease detection.
Innovation Solution
A system that includes a processor and memory for analyzing digital fundus images using a neural network to estimate optimal image capture time and disease state, enabling automated quality assessment and diagnosis without the need for mydriatic drugs, utilizing a fundus imaging system with a variable focus lens and image sensor array for capturing images at different diopter ranges.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If manual review of retinal images is used for diabetic retinopathy diagnosis, then diagnostic accuracy can be maintained through expert evaluation, but the process becomes labor-intensive and time-consuming
Solution Approach 1:
The patent replaces the mechanical manual review process with an automated digital image analysis system using neural networks and machine learning algorithms. The system automatically processes fundus images to detect diabetic retinopathy, eliminating the need for manual clinical review while maintaining diagnostic accuracy and significantly improving processing speed and efficiency
Solution Approach 2:
The system enables self-service diagnosis by automatically analyzing fundus images without requiring expert clinician intervention. The automated algorithm performs quality assessment, disease detection, and grading independently, allowing the system to serve itself in the diagnostic process while reducing dependency on manual expert evaluation
2Ease of operation
If traditional fundus imaging is used without mydriatic drugs, then patient convenience is improved, but image quality may be insufficient for accurate diagnosis
Solution Approach 1:
The patent changes the parameter of pupil state from dilated (requiring mydriatic drugs) to non-dilated (natural state). The system is specifically designed to capture and analyze fundus images in the non-mydriated state, maintaining patient convenience while achieving sufficient image quality through optimized imaging algorithms and neural network-based quality assessment
Solution Approach 2:
The patent replaces the chemical mechanism (mydriatic drugs) with an automated digital imaging and analysis system. Instead of using drugs to dilate the pupil, the system uses advanced camera technology and neural networks to capture and evaluate images in the natural pupil state, eliminating the need for pharmacological intervention
3Measurement precision
If multiple fundus images are captured across the depth of field, then diagnostic coverage is improved, but the complexity of image management increases
Solution Approach 1:
The patent merges multiple fundus images captured at different focus levels into a single composite image or manages them as an integrated set. The neural network system processes multiple images simultaneously, combining their diagnostic information to provide comprehensive retinal assessment while simplifying the management burden through automated processing and unified analysis
Data Source
AI summary
An example method for automating a quality assessment of digital fundus image can include: obtaining a digital fundus image file; analyzing a first quality of the digital fundus image file using a model to estimate an optimal time to capture a fundus image; and analyzing a second quality of the digital fundus image file using the model to estimate a disease state.